Figures & data
Figure 1 Pattern of persistence with monotherapy, fixed dose and free combination (prevalence, 95%CI).
Figure 2 Annual primary-care costs (median and IQR) by drug cohort and persistence category.
Patient Preference and Adherence
Volume 13, 2019 - Issue
Original Research
Fixed Versus Free Combinations Of Antihypertensive Drugs: Analyses Of Real-World Data Of Persistence With Therapy In Italy
Daria Putignano1 CIRFF, Center of Pharmacoeconomics, University of Naples Federico II, Naples, Italy
https://orcid.org/0000-0001-9021-5440
https://orcid.org/0000-0001-9021-5440, Valentina Orlando1 CIRFF, Center of Pharmacoeconomics, University of Naples Federico II, Naples, ItalyCorrespondence[email protected]
https://orcid.org/0000-0002-8209-8878
https://orcid.org/0000-0002-8209-8878, Valeria Marina Monetti1 CIRFF, Center of Pharmacoeconomics, University of Naples Federico II, Naples, Italyhttps://orcid.org/0000-0003-3832-0942
https://orcid.org/0000-0003-3832-0942, , , , Paola Minghetti3 Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, Milan, Italyhttps://orcid.org/0000-0001-7723-441X
https://orcid.org/0000-0001-7723-441X & Enrica Menditto1 CIRFF, Center of Pharmacoeconomics, University of Naples Federico II, Naples, Italyhttps://orcid.org/0000-0001-8633-5650
https://orcid.org/0000-0001-8633-5650 show all